FAQ: COVID-19 VACCINE POLICY

The deadline to receive a complete vaccination or upload a personal declination is June 1, 2021.

 

Once the U.S. Food and Drug Administration (FDA) grants full approval at least one of the vaccine, our draft policy requires proof of COVID-19 vaccination for all students, faculty, and staff participating in any in-person USC activity or coming to a USC campus or facility and personal declinations will no longer be accepted.

 

Any faculty, staff, or student who is unable to receive an FDA approved COVID-19 vaccine due to a disability or religious practice, belief, or observance, may request an exception to this policy once enacted. Further details will be announced by the university in the future.

Yes, all USC students and employees are eligible to receive vaccinations for COVID-19 at the Lyon Center through USC Student Health. Appointments are viewable through MySHR (https://usc.edu/myshr). Walk-ins are available from 8 am - 2 pm during vaccination hours.

 

Walk-in appointments are also available at Keck Medicine. Beginning Monday, April 26, through Saturday, May 1, Keck Medicine of USC will be accepting walk-in appointments at its Healthcare Center 3 (HC3) vaccination clinic, located on the Health Sciences Campus at 1516 San Pablo Street.

No please upload as soon as you have completed your vaccination/s.  If you received your vaccine from Keck or USC Student Health, your vaccination records will be automatically entered into the electronic health record within 7 days; no need to upload.

Please complete a Personal declination form and upload it to MySHR in the “Upload Documents” section.

Send an email to covid19@usc.edu with your name and USC ID number describing the problem, screenshots may be helpful. You may also call the Covid response center at 213-740-6291 or Student Health Center at 213-740-9355.

Please upload proof of vaccination into mySHR. At the present we are accepting all international COVID-19 vaccines that are approved by the World Health Organization (WHO) or any governing regulatory body.  We are continually evaluating efficacy data for these vaccines and further recommendations on additional doses of a COVID-19 vaccine may be updated in the future.

No Content
Tabular data